Tango Therapeutics shares are trading lower after the company announced the discontinuation of its TNG348 program.
Portfolio Pulse from Benzinga Newsdesk
Tango Therapeutics shares are trading lower after the company announced the discontinuation of its TNG348 program.
May 23, 2024 | 11:02 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Tango Therapeutics shares are trading lower following the announcement of the discontinuation of its TNG348 program.
The discontinuation of the TNG348 program is a significant event for Tango Therapeutics, likely leading to a negative short-term impact on the stock price as investors react to the halted development.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100